Squarepoint Ops LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 81 filers reported holding IMMUNE DESIGN CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q2 2018$46,000
-67.4%
10,111
-72.1%
0.00%
-50.0%
Q4 2017$141,000
+6.8%
36,250
+168.5%
0.00%
-33.3%
Q2 2017$132,000
-15.4%
13,500
-41.3%
0.00%
-25.0%
Q1 2017$156,000
+88.0%
22,983
+52.8%
0.00%
+33.3%
Q4 2016$83,00015,0420.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$3,532,0000.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 140,720$2,485,0000.10%
SECTORAL ASSET MANAGEMENT INC 95,000$1,678,0000.07%
Spark Investment Management LLC 18,900$329,0000.05%
Alyeska Investment Group, L.P. 46,833$827,0000.02%
FRANKLIN RESOURCES INC 802,000$14,163,0000.01%
Focused Wealth Management, Inc 450$8,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 740,241$13,073,0000.00%
FMR LLC 900,000$15,894,0000.00%
BlackRock Fund Advisors 149,938$2,648,0000.00%
View complete list of IMMUNE DESIGN CORP shareholders